Decellularized Stented Heart Valve (DGH)
Surgical Aortic Valve Replacement
DevelopmentActive
Key Facts
About AutoTissue
AutoTissue is a private, commercial-stage biotech company pioneering glutaraldehyde-free, decellularized tissue implants for cardiovascular repair. Its core technology platform removes cellular material to minimize immunogenicity, with its lead commercial product, the Matrix Patch™ equine, used in pediatric cardiac surgery and adult aortic valve repair. The company operates a hybrid business model, combining product sales with contract research and manufacturing services, and is actively developing next-generation products like a decellularized stented heart valve.
View full company profile